Published on in Vol 9, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29017, first published .
An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

Journals

  1. O'Rourke J, Warnick J, Doole J, De Keyser L, Drebert Z, Wan O, Thompson C, London J, Fairchild K, Palchuk M. Exploring Breast Cancer Systemic Drug Therapy Patterns in Real-World Data. JCO Clinical Cancer Informatics 2023;(7) View
  2. Gendrin A, Souliotis L, Loudon-Griffiths J, Aggarwal R, Amoako D, Desouza G, Dimitrievska S, Metcalfe P, Louvet E, Sahni H. Identifying Patient Populations in Texts Describing Drug Approvals Through Deep Learning–Based Information Extraction: Development of a Natural Language Processing Algorithm. JMIR Formative Research 2023;7:e44876 View
  3. Ru B, Sillah A, Desai K, Chandwani S, Yao L, Kothari S. Real-World Data Quality Framework for Oncology Time to Treatment Discontinuation Use Case: Implementation and Evaluation Study. JMIR Medical Informatics 2024;12:e47744 View
  4. Liu S, Dasgupta A, Latremouille-Viau D, Rossi C, Rai P, Barlesi F, Leal T. Real-World Outcomes of First-Line Treatment With Anti–PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States. JCO Global Oncology 2024;(10) View